Eculizumab vs placebo
Overall survival ‐ not measured · patients with paroxysmal nocturnal hemoglobinuria
1 finding from 1 review
- Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria 2014 · Cochrane Headline outcomes onlyno estimate extracted1 study · 87 participantsGRADE not reported